ストックスクリーナーアプリを入手
17.50
2.13%
-0.38
アフターアワーズ：
17.53
0.03
+0.17%
Clearpoint Neuro Inc (CLPT) 最新ニュース
(CLPT) Risk Channels and Responsive Allocation - Stock Traders Daily
ClearPoint Neuro (CLPT) surges 26.0%: Is this an indication of further gains? - MSN
Form 4 Clearpoint Neuro Inc For: 6 July By Investing.com - Investing.com Canada
Director at ClearPoint Neuro (NASDAQ: CLPT) receives 222-share stock grant - Stock Titan
ClearPoint Neuro (CLPT) Holds Steady Near $18.72 as Traders Eye Key Support and Resistance LevelsLong Term Entry Picks - dars.gov.et
CLPTClearPoint Neuro Inc Volatility & Greeks - Finviz
ClearPoint Neuro outlines growth ambitions in precision neurosurgery - ad-hoc-news.de
Form 4 Clearpoint Neuro Inc For: 2 July By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) CBO adds 1,781 ESPP shares, now holds 110,263 - Stock Titan
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer STIGALL L. JEREMY - Moomoo
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer D'Alessandro Danilo - Moomoo
ClearPoint Neuro (CLPT) CFO acquires 1,085 shares through ESPP - Stock Titan
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer BURNETT JOSEPH - Moomoo
Clearpoint Neuro Insider Sold Shares Worth $387,600, According to a Recent SEC Filing - marketscreener.com
ClearPoint Neuro CEO Burnett sells $387,600 in company shares By Investing.com - Investing.com Nigeria
ClearPoint Neuro CEO Burnett sells $387,600 in company shares - Investing.com
Form 4 Clearpoint Neuro Inc For: 1 July By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) CEO exercises options and sells 20,000 shares under 10b5-1 plan - Stock Titan
Price to sales forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Price to book forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Price to earnings forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Enterprise value to EBITDA forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
(CLPT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Director sale notice, CLPT (NASDAQ: CLPT) — 20,000 shares via option exercise - Stock Titan
ClearPoint Neuro | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Enterprise value to EBIT forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Enterprise value to revenue forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
ClearPoint Neuro, Inc. Actuals & Estimates (NASDAQ:CLPT) - TradingView
CLPT Forecast — Price Target — Prediction for 2027 - TradingView
Compared to estimates, ClearPoint Neuro (CLPT) Q1 earnings: A look at key metrics - MSN
ClearPoint Neuro, Inc. (CLPT) reports Q1 loss, lags revenue estimates - MSN
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Announces Target Price $30 - Moomoo
ClearPoint Neuro (CLPT) Surges 8.6% as Bullish Momentum BuildsTriple Top - dars.gov.et
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), uniQure (QURE) - The Globe and Mail
ClearPoint Neuro (CLPT) CEO sells 61,843 shares after exercising options - Stock Titan
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating - Moomoo
Stifel Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $25 - Moomoo
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), Tyra Bioscience (TYRA) - The Globe and Mail
Liquidity Mapping Around (CLPT) Price Events - Stock Traders Daily
CLPT Maintained by B. Riley Securities -- Price Target Raised to $30 - GuruFocus
ClearPoint Neuro Is Maintained at Buy by B. Riley Securities - Moomoo
B. Riley Securities Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $30 - Moomoo
Clearpoint Neuro Inc (CLPT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ClearPoint Neuro: AMT-130's FDA Reversal Revives The Bull Case (NASDAQ:CLPT) - Seeking Alpha
B. Riley Adjusts ClearPoint Neuro Price Target to $30 From $20, Maintains Buy Rating - marketscreener.com
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains? - Yahoo Finance
Clearpoint Neuro Inc (CLPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Analysts Offer Insights on Healthcare Companies: Verastem (VSTM) and ClearPoint Neuro (CLPT) - The Globe and Mail
Clearpoint Neuro Inc (CLPT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Clearpoint Neuro Inc (CLPT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Clearpoint Neuro Inc (CLPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Clearpoint Neuro Inc (CLPT) Institutional Confidence - TradingKey
Clearpoint Neuro Inc (CLPT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Clearpoint Neuro Inc (CLPT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Clearpoint Neuro Inc (CLPT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
[144] ClearPoint Neuro, Inc. SEC Filing - Stock Titan
ClearPoint Neuro (CLPT) Sees Significant Pre-Market Gains Following Partner Announcement - GuruFocus
2.36%
大文字化:
|
ボリューム (24 時間):